Antidepressants Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Selective Serotonin Reuptake Inhibitors, Serotonin & Norepinephrine Reuptake Inhibitors, Atypical Antidepressants, Tricyclic Antidepressants), By Disorder (Major Depressive Disorder, Obsessive-Compulsive Disorder, Generalized Anxiety Disorder), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), and Regional Forecast, 2020-2027

  ATTRIBUTE

  DETAILS

Study Period

  2016-2027

Base Year

  2019

Forecast Period

  2020-2027

Historical Period

  2016-2018

Unit

  Value (USD Billion)

Segmentation

  Drug Class; Disorder; Distribution Channel; and Region

By Drug Class

• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
• Atypical Antidepressants
• Tricyclic Antidepressants (TCAs)
• Monoamine Oxidase Inhibitors (MAOIs)
• Others

By Disorder

• Major Depressive Disorder
• Obsessive Compulsive Disorder
• Generalized Anxiety Disorder
• Panic Disorder
• Others

By Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

By Geography

• North America
  • By Drug Class
  • By Disorder
  • By Distribution Channel
  • By Country
    • The USA (By Disorder)
    • Canada (By Disorder)
• Europe
  • By Drug Class
  • By Disorder
  • By Distribution Channel
  • By Country
    • The UK (By Disorder)
    • Germany (By Disorder)
    • France (By Disorder)
    • Italy (By Disorder)
    • Spain (By Disorder)
    • Scandinavia (By Disorder)
    • Rest of Europe (By Disorder)
• Asia Pacific
  • By Drug Class
  • By Disorder
  • By Distribution Channel
  • By Country
    • Japan (By Disorder)
    • China (By Disorder)
    • India (By Disorder)
    • Australia (By Disorder)
    • Southeast Asia (By Disorder)
    • Rest of Asia Pacific (By Disorder)
• Latin America
  • By Drug Class
  • By Disorder
  • By Distribution Channel
  • By Country
    • Brazil (By Disorder)
    • Mexico (By Disorder)
    • Rest of Latin America (By Disorder)
• The Middle East & Africa
  • By Drug Class
  • By Disorder
  • By Distribution Channel
  • By Country
    • GCC (By Disorder)
    • South Africa (By Disorder)
    • Rest of the MEA (By Disorder)